글로벌 질 칸디다증 치료 시장 - 2028년까지의 산업 동향 및 예측

시장 분석 및 통찰력 : 글로벌 질 칸디다증 치료 시장

질 칸디다증 치료 시장은 2021-2028년 예측 기간 동안 시장 성장을 이룰 것으로 예상됩니다. Data Bridge Market Research는 위에서 언급한 예측 기간 동안 시장이 5.7%의 CAGR로 성장할 것으로 분석합니다.

질 칸디다증은 칸디다라는 종류의 곰팡이에 의해 발생하는 곰팡이 감염입니다 . 일반적으로 입, 질, 목, 내장, 피부와 같은 신체의 여러 부위에 서식합니다. 이 질환은 비정상적인 질 분비물, 질 가려움증, 성관계 시 통증, 배뇨 시 통증 및 발적이 특징입니다. 질 효모 감염, 외음부 질 칸디다증 또는 칸디다 질염이라고도 합니다.

질 칸디다증 유병률 증가와 항생제의 불필요한 소비는 시장 성장률에 영향을 미치는 주요 요인입니다. 또한, 증가하는 의료비 지출, 비만 및 당뇨병 발병률 증가 , 증가하는 정부 자금 지원, 질병과 예방 조치에 대한 인식을 확산하기 위한 정부 및 민간 기관의 이니셔티브 증가는 질 칸디다증 치료 시장을 확대할 요인입니다.

2021~2028년 예측 기간 동안 연구 개발 활동과 신흥 시장의 증가는 질 칸디다증 치료 시장에 유익한 기회를 제공할 것입니다.

그러나 치료 비용이 높고 치료와 관련된 부작용이 시장 성장을 방해하는 요인입니다. 질병에 대한 인식 부족과 침습적 칸디다증과 같은 합병증은 위에서 언급한 예측 기간 동안 질 칸디다증 치료 시장에 더욱 큰 도전이 될 것입니다.

This vaginal candidiasis treatment market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the vaginal candidiasis treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Vaginal Candidiasis Treatment Market Scope and Market Size

The vaginal candidiasis treatment market is segmented on the basis of treatment, diagnosis, dosage, route of administration, symptoms, end-users and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

• On the basis of treatment, the vaginal candidiasis treatment market is segmented into antifungal drugs and others. Antifungal drugs have been further sub-segmented into clotrimazole, butoconazole, terconazole, miconazole and tioconazole.
• On the basis of diagnosis, the vaginal candidiasis treatment market is segmented into pelvic exam, vaginal secretion test and others.
• On the basis of dosage, the vaginal candidiasis treatment market is segmented into tablet, injection and others.
• On the basis of route of administration, the vaginal candidiasis treatment market is segmented into oral, intravenous and others.
• On the basis of symptoms, the vaginal candidiasis treatment market is segmented into abnormal vaginal discharge, vaginal itching, pain during sexual intercourse, pain while urinating and others.
• On the basis of end-users, the vaginal candidiasis treatment market is segmented into clinic, hospital and others.

The vaginal candidiasis treatment market is also segmented on the basis of distribution channel into hospital pharmacy, retail pharmacy and online pharmacy.

Vaginal Candidiasis Treatment Market Country Level Analysis

Vaginal candidiasis treatment market is analyzed and market size information is provided by the country, treatment, diagnosis, dosage, route of administration, symptoms, end-users and distribution channel as referenced above.

The countries covered in the vaginal candidiasis treatment market report are the U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa.

North America dominates the vaginal candidiasis treatment market due to the presence of major key players, high disposable income, high healthcare expenditure and well-developed healthcare sector in this region. Asia-Pacific is expected to grow during the forecast period of 2021-2028 due to the increasing research and development activities, rising investment in the healthcare sector and growing government support.

The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Patient Epidemiology Analysis

Vaginal candidiasis treatment market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

Competitive Landscape and Global Vaginal Candidiasis Treatment Market Share Analysis

Vaginal candidiasis treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to global vaginal candidiasis treatment market research.

질 칸디다증 치료 시장 보고서에 포함된 주요 기업은 Merck Sharp & Dohme Corp., Pfizer Inc., GlaxoSmithKline plc, Bayer AG, Sun Pharmaceutical Industries Ltd., Sanofi, Novartis AG, Glenmark Pharmaceuticals Limited, Abbott, Astellas Pharma Inc., Gilead Sciences, Inc., Enzon Pharmaceuticals, Inc., SCYNEXIS, Inc., Merck KGaA, Leadiant Biosciences, Inc., Bausch Health Companies Inc., Beckman Coulter, Inc., Basilea Pharmaceutica Ltd., Agilent Technologies, Inc. 등 국내 및 글로벌 기업입니다. 시장 점유율 데이터는 글로벌, 북미, 유럽, 아시아 태평양(APAC), 중동 및 아프리카(MEA) 및 남미에 대해 개별적으로 제공됩니다. DBMR 분석가는 경쟁 우위를 이해하고 각 경쟁자에 대한 경쟁 분석을 개별적으로 제공합니다.

SKU-66873